Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1865 1
1930 1
1932 2
1933 1
1935 1
1970 1
1971 1
1973 1
1974 1
1975 7
1976 3
1977 4
1978 5
1979 8
1980 3
1981 3
1982 5
1983 3
1984 10
1985 15
1986 6
1987 26
1988 15
1989 18
1990 11
1991 12
1992 18
1993 15
1994 21
1995 26
1996 40
1997 14
1998 12
1999 21
2000 18
2001 20
2002 16
2003 19
2004 37
2005 32
2006 23
2007 28
2008 25
2009 40
2010 39
2011 54
2012 41
2013 57
2014 68
2015 61
2016 64
2017 67
2018 93
2019 83
2020 76
2021 80
2022 66
2023 61
2024 44
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,388 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: chambers sk. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: chambers s. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
Re-imagining Psycho-oncology.
Chambers SK, Dunn J. Chambers SK, et al. Eur J Cancer Care (Engl). 2019 Jul;28(4):e13136. doi: 10.1111/ecc.13136. Eur J Cancer Care (Engl). 2019. PMID: 31318133 No abstract available.
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, No… See abstract for full author list ➔ Schumacher FR, et al. Among authors: chambers s. Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11. Nat Genet. 2018. PMID: 29892016 Free PMC article.
Build-a-brain.
Chambers SM, Tchieu J, Studer L. Chambers SM, et al. Cell Stem Cell. 2013 Oct 3;13(4):377-8. doi: 10.1016/j.stem.2013.09.010. Cell Stem Cell. 2013. PMID: 24094317 Free article.
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Tanyi JL, Randall LM, Chambers SK, Butler KA, Winer IS, Langstraat CL, Han ES, Vahrmeijer AL, Chon HS, Morgan MA, Powell MA, Tseng JH, Lopez AS, Wenham RM. Tanyi JL, et al. Among authors: chambers sk. J Clin Oncol. 2023 Jan 10;41(2):276-284. doi: 10.1200/JCO.22.00291. Epub 2022 Sep 7. J Clin Oncol. 2023. PMID: 36070540 Clinical Trial.
eHealth literacy in prostate cancer: A systematic review.
Jackson SR, Yu P, Armany D, Occhipinti S, Chambers S, Leslie S, Patel MI. Jackson SR, et al. Among authors: chambers s. Patient Educ Couns. 2024 Jun;123:108193. doi: 10.1016/j.pec.2024.108193. Epub 2024 Feb 7. Patient Educ Couns. 2024. PMID: 38354430 Free article.
Animal Models of Diverticulosis: Review and Recommendations.
Patel B, Guo X, Noblet J, Chambers S, Kassab GS. Patel B, et al. Among authors: chambers s. Dig Dis Sci. 2018 Jun;63(6):1409-1418. doi: 10.1007/s10620-018-5071-y. Epub 2018 Apr 20. Dig Dis Sci. 2018. PMID: 29679297 Review.
Barriers to home bowel cancer screening.
Goodwin BC, Myers L, Ireland MJ, March S, Ralph N, Dunn J, Chambers S, Aitken J. Goodwin BC, et al. Among authors: chambers s. Psychooncology. 2021 Oct;30(10):1756-1764. doi: 10.1002/pon.5741. Epub 2021 Jun 3. Psychooncology. 2021. PMID: 34044472
1,388 results